SCHEMBL21889529

SCHEMBL21889529

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1nc(-n2c3ccccc3c3ccccc32)c(-n2c3ccccc3c3ccccc32)c(-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)c1-n1c2ccccc2c2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
KDM4E B2RXH2 8/20 0.39
ALDH1A1 P00352 8/20 0.39
MAPT P10636 8/20 0.39
LMNA P02545 5/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HSD17B10 Q99714 1/20 0.39
RECQL P46063 1/20 0.39
HPGD P15428 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
AGTR1 P30556 1/20 0.36
GAA P10253 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP3A4 P08684 2/20 0.35
MAPK1 P28482 1/20 0.35
FLT3 P36888 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21888573 1.00 KMT2A (0.39) KMT2AMEN1KDM4EALDH1A1MAPT
SCHEMBL21889543 1.00 KMT2A (0.39) KMT2AMEN1KDM4EALDH1A1MAPT
SCHEMBL30338803 1.00 KMT2A (0.39) KMT2AMEN1KDM4EALDH1A1MAPT
SCHEMBL30338809 1.00 KMT2A (0.39) KMT2AMEN1KDM4EALDH1A1MAPT
SCHEMBL30339518 1.00 KMT2A (0.39) KMT2AMEN1KDM4EALDH1A1MAPT
SCHEMBL30338963 1.00 KMT2A (0.39) KMT2AMEN1KDM4EALDH1A1MAPT
SCHEMBL30338967 1.00 KMT2A (0.39) KMT2AMEN1KDM4EALDH1A1MAPT
SCHEMBL21889544 0.96 KMT2A (0.42) KMT2AMEN1KDM4EALDH1A1MAPT
SCHEMBL30339200 0.96 KMT2A (0.42) KMT2AMEN1KDM4EALDH1A1MAPT
SCHEMBL21889099 0.93 KMT2A (0.43) KMT2AMEN1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3642303-B1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2021-04-14 EP disclosed
US-20200115376-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115376-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, NDUFV3, SLCO1B3 KMT2A 4167/4885MEN1 3155/4885KDM4E 4275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.